Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis

NCT03749317 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenoviral Conjunctivitis

Interventions

DRUG: IVIEW-1201
DRUG: Placebo

Sponsor

IVIEW Therapeutics Inc.